Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) ...

Strangers and friends have raised more than $150k for a man’s experimental life-saving cancer treatment after he found out ...

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous PolyposisUnderscores unmet need for a ...

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...

Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

sublobar resection. Researchers are working on a long-term risk calculator with these real-world data. Among patients with stage IA non-small cell lung cancer, long-term survival was better with ...

This study presents an important finding that has identified 27 differentially methylated regions as a signature for non-invasive early cancer detection and predicting prognosis for colorectal cancer.

The waste then moves through the rectum and exits the body through the anus. Rectal cancer originates in the rectum, the final several inches of the large intestine, closest to the anus.

Low anterior resection syndrome (LARS) is also known as anterior resection syndrome. It’s a collection of bowel symptoms that can happen after surgery to remove all or part of your rectum. These ...

aiming to evaluate the Signatera test in personalising adjuvant treatment strategies for stage III and high-risk stage II colon cancer subjects after surgical resection. "Natera reports new data from ...